Scientists uncover “genomic tug of war” that influences chemotherapy’s effectiveness

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine’s effects or become resistant over time.

Royalty Pharma inks MS deal with ImmuNext; X4 sells its priority review voucher

Plus, news about Pacira Biosciences, Cassava Sciences, Merck, Monopar Therapeutics, Eli Lilly and Optinose: Royalty Pharma signs MS deal: The company will pay about $525

May 10, 2024

Traffic-related air pollution raises blood pressure, study finds

For more than a century, American cities have been sliced and diced by high-traffic roadways. Interstate highways and wide arterials are now a defining feature

November 28, 2023

Roche begins Phase 2 obesity trial for GLP-1/GIP agonist, striking while iron is hot

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.